Anti-IgE Treatment with Oral Immunotherapy in Multifood Allergic Participants: Results of a Randomized, Double-blinded Control Trial

BACKGROUND: Despite progress in single food oral immunotherapy (OIT), there is little evidence concerning the safety and efficacy of treating individuals with multiple food (multifood) allergies. We conducted a pilot study testing whether anti-IgE (omalizumab) combined with multifood OIT benefitted...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Lancet Gastroenterol Hepatol
Asıl Yazarlar: Andorf, Sandra, Purington, Natasha, Block, Whitney M., Long, Andrew J., Tupa, Dana, Brittain, Erica, Spergel, Amanda Rudman, Desai, Manisha, Galli, Stephen J., Nadeau, Kari C., Chinthrajah, R. Sharon
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2017
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6944204/
https://ncbi.nlm.nih.gov/pubmed/29242014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2468-1253(17)30392-8
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller